glp-1 inflammation A Closer Look at the Dermatological Profile of Agonists GLP-1 Agonists in Cardiovascular Diseases:

Wegovy may contribute to an increased risk for thyroid c-cell tumors, acute pancreatitis, gallbladder disease, hypoglyceia, acute kidney injury, severe GI side effects, and an increased risk for worsening of diabetic retinopathy in people with type 2 diabetes

As GLP-1 therapies expand beyond diabetes and obesity, understanding their anti-inflammatory mechanisms may unlock new therapeutic uses

Tian F, Xu W, Chen L, Chen T, Feng X, Chen J, et al

It helps determine myocardial viability, detect areas of cardiac injury and also helps the insurance payer to check for approval criteria

Likewise, sex differences in the way some of these drugs are absorbed and metabolized has been noted 37 , though we did not observe any differences in L2-Cmu PK or exposure levels between male and female animals